|
|
|
|
|
|
|
|
|
|
Daily aspirin reduces colorectal cancer incidence in patients with Lynch syndrome - Barton - 2012 - CA: A Cancer Journal for Clinicians
"According to the investigators, this study, along with earlier data, supports the use of aspirin in the chemoprevention treatment of patients with Lynch syndrome, although the dose and timing of use have not been established. A CAPP3 study is planned that will investigate optimizing the dose and duration. (More information can be found at www.CAPP3.org.)"
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.